Expert shares the promising potential of linvoseltamab in treating high-risk smoldering multiple myeloma.
Paula Rodriguez-Otero, MD, PhD
Advertisement
Articles by Paula Rodriguez-Otero, MD, PhD
Experts discuss the potential of linvoseltamab in treating high-risk smoldering multiple myeloma, highlighting promising early trial results and response rates.
Advertisement
Latest Updated Articles
IMS 2025: Pharmacist Perspectives on Safety, Early Treatment, and Education in Multiple MyelomaPublished: September 23rd 2025 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Mind the Gap: Pharmacy’s Future as AI Evolves in Health Care
2
New Report Details Rising Incidence of Invasive Lobular Carcinoma
3
Breaking News: AstraZeneca, White House Announce Most-Favored-Nation Deal
4
The 3 Skills You Will Need Most
5
